|Values are valid only on day of printing.|
The qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent
This test is designed to provide, when possible, the identification of all drugs present.
This test looks for a broad spectrum of prescription and over-the-counter (OTC) drugs. It is designed to detect drugs that have toxic effects, as well as known antidotes or active therapies that a clinician can initiate to treat the toxic effect. The test is intended to help physicians manage an apparent overdose or intoxicated patient, or to determine if a specific set of symptoms might be due to the presence of drugs. The test is not designed to screen for intermittent use or illicit drugs.
Drugs of toxic significance that are not detected by this test are: digoxin, lithium, and many drugs of abuse/illicit drugs, some benzodiazepines, and some opioids.
See Prescription and Over-the-Counter (OTC) Drug Screens in Special Instructions.
The drugs that can be detected by this test are listed in Prescription and Over-the-Counter (OTC) Drug Screens in Special Instructions.
Drugs of toxic significance that are not detected by this test include digoxin, lithium, many drugs of abuse/illicit drugs, some benzodiazepines, and some opiates. For these drugs, see Mayo Medical Laboratories' drug abuse surveys or drug screens or individual tests.
A detailed discussion of each drug detected is beyond the scope of this text. Each report will indicate the drugs identified. If a clinical interpretation is required, request a Drug/Toxicology Lab consult (Mayo Clinic patients) or contact Mayo Laboratory Inquiry (Mayo Medical Laboratories clients).
Not intended for use in employment-related testing.
Not intended for therapeutic compliance testing.
1. Tietz Textbook of Clinical Chemistry. Third edition. Edited by CA Burtis, ER Ashwood. Philadelphia, WB Saunders Company 1999, pp 913-917
2. Disposition of Toxic Drugs and Chemicals in Man. Fifth edition. Edited by RC Baselt, RH Cravey. Foster City, CA, Chemical Toxicology Institute, 2000